SBC Medical Group (SBC) to Release Quarterly Earnings on Thursday

SBC Medical Group (NASDAQ:SBC) is expected to announce its Q1 2026 results before the market opens on Thursday, May 14th. Analysts expect the company to announce earnings of $0.10 per share and revenue of $41.6580 million for the quarter. Investors can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Thursday, May 14, 2026 at 8:30 AM ET.

SBC Medical Group (NASDAQ:SBC) last posted its quarterly earnings results on Friday, March 27th. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.13 by $0.01. The business had revenue of $39.57 million during the quarter, compared to analyst estimates of $45.19 million. SBC Medical Group had a net margin of 29.37% and a return on equity of 20.76%. On average, analysts expect SBC Medical Group to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

SBC Medical Group Trading Down 0.6%

Shares of NASDAQ:SBC opened at $3.16 on Tuesday. The company has a market cap of $324.15 million, a PE ratio of 6.45 and a beta of 0.61. The company’s 50-day moving average price is $3.81 and its 200 day moving average price is $3.95. SBC Medical Group has a fifty-two week low of $2.97 and a fifty-two week high of $5.75. The company has a quick ratio of 3.74, a current ratio of 3.78 and a debt-to-equity ratio of 0.13.

Insiders Place Their Bets

In related news, CEO Yoshiyuki Aikawa sold 465,000 shares of SBC Medical Group stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $3.02, for a total value of $1,404,300.00. Following the sale, the chief executive officer directly owned 78,839,460 shares in the company, valued at $238,095,169.20. This trade represents a 0.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In the last 90 days, insiders have sold 7,987,900 shares of company stock valued at $20,142,848. Company insiders own 89.47% of the company’s stock.

Institutional Trading of SBC Medical Group

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. bought a new stake in shares of SBC Medical Group during the 4th quarter worth about $49,000. Russell Investments Group Ltd. raised its position in shares of SBC Medical Group by 292.0% during the 4th quarter. Russell Investments Group Ltd. now owns 11,775 shares of the company’s stock worth $51,000 after buying an additional 8,771 shares in the last quarter. Nuveen LLC bought a new stake in shares of SBC Medical Group during the 4th quarter worth about $53,000. Wells Fargo & Company MN raised its position in shares of SBC Medical Group by 195.1% during the 4th quarter. Wells Fargo & Company MN now owns 12,626 shares of the company’s stock worth $54,000 after buying an additional 8,348 shares in the last quarter. Finally, XTX Topco Ltd bought a new stake in shares of SBC Medical Group during the 2nd quarter worth about $64,000. 60.82% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on SBC. Weiss Ratings upgraded shares of SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday. Wall Street Zen upgraded shares of SBC Medical Group to a “hold” rating in a research report on Saturday. Finally, BTIG Research began coverage on shares of SBC Medical Group in a research report on Friday, March 6th. They issued a “buy” rating and a $8.00 price objective on the stock. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $8.50.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.